CLINICAL TRIALS PROFILE FOR NORPACE
✉ Email this page to a colleague
All Clinical Trials for NORPACE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00589303 ↗ | AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study | Terminated | Medtronic | Phase 3 | 2007-12-01 | The purpose of this study is to determine whether early atrioventricular node (AVN) ablation with pacing device therapy will reduce death and hospitalization when compared to the conventional drug therapy in elderly patients with recurrent and symptomatic atrial fibrillation (AF). |
NCT00589303 ↗ | AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study | Terminated | Mayo Clinic | Phase 3 | 2007-12-01 | The purpose of this study is to determine whether early atrioventricular node (AVN) ablation with pacing device therapy will reduce death and hospitalization when compared to the conventional drug therapy in elderly patients with recurrent and symptomatic atrial fibrillation (AF). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NORPACE
Condition Name
Clinical Trial Locations for NORPACE
Trials by Country
Clinical Trial Progress for NORPACE
Clinical Trial Phase
Clinical Trial Sponsors for NORPACE
Sponsor Name